Rapid Micro Biosystems (RPID) Liabilities and Shareholders Equity (2020 - 2026)

Rapid Micro Biosystems has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $62.4 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $62.4 million, down 27.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $297.2 million (down 26.89% YoY), and the FY2025 annual result was $74.9 million, down 23.75% from the prior year.
• Liabilities and Shareholders Equity came in at $62.4 million for Q1 2026 at Rapid Micro Biosystems, down from $74.9 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $230.1 million in Q1 2022 to a low of $62.4 million in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $127.7 million (2024), against an average of $135.2 million.
• Across the five-year window, Liabilities and Shareholders Equity surged 67.24% in 2022 and slumped 35.44% in 2025, its largest moves.
• Rapid Micro Biosystems' Liabilities and Shareholders Equity stood at $190.6 million in 2022, then retreated by 24.76% to $143.5 million in 2023, then plunged by 31.57% to $98.2 million in 2024, then decreased by 23.75% to $74.9 million in 2025, then slipped by 16.68% to $62.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $62.4 million (Q1 2026), $74.9 million (Q4 2025), and $84.4 million (Q3 2025), per Business Quant data.